This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Amelie Dommergue: Inventor in Therapeutic Chemistry.
Introduction
Amelie Dommergue is an inventor associated with Sanofi in Paris, France. Her patent work concerns compounds investigated for potential therapeutic use, including as anticancer agents.
Latest Patents
Dommergue is credited with 1 patent: “Imidazo[1,2-b][1,2,4]triazol Derivatives for Use in Therapy.” The patent describes compounds and pharmaceutically acceptable salts, with variations in their chemical substituents and aromatic or heteroaromatic structures. It also addresses therapeutic applications, particularly potential use as anticancer agents.
Career Highlights
Her listed invention reflects research at the intersection of medicinal chemistry and therapeutic development. The patent identifies Sanofi as the company associated with her work.
Collaborations
Danielle De Peretti and Antonio Almario are listed as Dommergue’s coworkers.
Conclusion
Amelie Dommergue’s patent record highlights her contribution to research into chemical compounds with potential therapeutic applications, including cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile